Unichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling
- Date
- Aug 27, 2025
- Company
- Unichem Pharmaceuticals
- Brand
- Unichem Pharmaceuticals
- Product
- Cyclobenzaprine Hydrochloride Tablets USP 10 mg
- Reason
- Device & Drug Safety – Mislabel
- Hazard
- Other
- Source
- FDA
How to identify the product
- FOR IMMEDIATE RELEASE – 08/27/2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, to the consumer level.
- The mislabeled bottles of Cyclobenzaprine Hydrochloride Tablets USP, 10mg but containing Meloxicam 7.5mg tablets, can be identified by the lot number GMML24026A and expiry of Sept 2027 and NDC 29300-415-19 printed on the label of the 90-count bottles.
- The product was distributed Nationwide to distributors, and further downstream distribution occurred to retailers and subsequently consumers.
- Inmar is arranging for the return of the subject recalled Cyclobenzaprine Hydrochloride Tablets USP, 10mg labeled with Lot # GMML24026A.
- Our downstream trading partners that have Cyclobenzaprine Hydrochloride Tablets USP, 10mg with Lot# GMML24026A, Exp Sept 2027, which is being recalled, should not further distribute, this medication, and notify their customers accordingly.
- Retail pharmacies should not dispense from this lot number, GMML24026A, and call the number provided for guidance on how to return this drug product.
Where to find the lot number or date code on your package →
Product photos are on the official FDA page.
Facts are taken from the official notice. If anything here differs from it, the official notice is correct.